H. Baird Radford, III, is Executive Vice President and Chief Financial Officer of Omnicell Inc., a leading provider of medication management solutions and digital health technologies for healthcare organizations worldwide. Appointed to this role in April 2021, Radford oversees all aspects of the company's global finance organization, including financial planning and analysis, treasury, tax, accounting, investor relations, and risk management. His strategic leadership has been pivotal in driving Omnicell's financial discipline, supporting organic growth, and executing key acquisitions to expand the company's portfolio in pharmacy automation and intelligent workflows. With more than 25 years of finance experience in the healthcare and medical technology sectors, Radford previously served as Chief Financial Officer at Integra LifeSciences Holdings Corporation from 2017 to 2021. There, he spearheaded financial transformation initiatives that delivered sustained revenue growth, improved profitability, and enhanced operational efficiency during a period of portfolio optimization and international expansion. Earlier in his career, he held progressive leadership roles at Covidien plc (now part of Medtronic), including Vice President of Finance for the Medical Supplies business unit, where he managed multimillion-dollar P&L responsibilities and navigated the company's landmark acquisition. Radford began his professional journey at General Electric Company, advancing through commercial finance and corporate audit positions that honed his expertise in strategic planning and business operations. A certified public accountant, he holds a Bachelor of Science in Accounting from the University of Richmond and an MBA from the College of William & Mary. Under his stewardship at Omnicell, the company has strengthened its balance sheet, advanced shareholder value, and positioned itself as an innovator in addressing critical healthcare challenges like medication adherence and supply chain resilience.